OPI-001

N/A

Report date: 2024/09/20 17:13:56
NME

Base Information

Drug NameOPI-001
Drug Alias NameOPI-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHearing Loss
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOtologic Pharmaceutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesOtologic Pharmaceutics Inc
Inactive CompaniesN/A
Active IndicationsHearing Loss
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A